Dr. Kepal Patel

Oh, I would say probably like 30 to 40%. Really? Oh yeah, they want to see what their thyroid looks like.

We'll take a picture.

We'll take a picture.

We'll take a picture.

Yes. So thyroid cancers are thyroid nodules that are malignant.

Yes. So thyroid cancers are thyroid nodules that are malignant.

Yes. So thyroid cancers are thyroid nodules that are malignant.

No, no. So thyroid cancers are basically thyroid nodules that are malignant nodules of thyroid cancers. It's actually one of the, I think one of the most interesting and I'm not biased. I think it's one of the most interesting cancers in the human body. And the reason for that, it really spans the entire spectrum from like being one of the most indolent cancers where the prognosis is excellent.

No, no. So thyroid cancers are basically thyroid nodules that are malignant nodules of thyroid cancers. It's actually one of the, I think one of the most interesting and I'm not biased. I think it's one of the most interesting cancers in the human body. And the reason for that, it really spans the entire spectrum from like being one of the most indolent cancers where the prognosis is excellent.

No, no. So thyroid cancers are basically thyroid nodules that are malignant nodules of thyroid cancers. It's actually one of the, I think one of the most interesting and I'm not biased. I think it's one of the most interesting cancers in the human body. And the reason for that, it really spans the entire spectrum from like being one of the most indolent cancers where the prognosis is excellent.

So if you have what's called papillary thyroid cancer, classic papillary cancer.

So if you have what's called papillary thyroid cancer, classic papillary cancer.

So if you have what's called papillary thyroid cancer, classic papillary cancer.

the overall survival is 95%, 20-year survival. You almost don't get that in any cancer other than small skin cancers. So you have on one end of the spectrum, one of the most treatable cancers in the human body.

the overall survival is 95%, 20-year survival. You almost don't get that in any cancer other than small skin cancers. So you have on one end of the spectrum, one of the most treatable cancers in the human body.

the overall survival is 95%, 20-year survival. You almost don't get that in any cancer other than small skin cancers. So you have on one end of the spectrum, one of the most treatable cancers in the human body.

And then you have something called anaplastic or undifferentiated thyroid cancers, which probably is the most aggressive thyroid cancer in the human body with basically a mortality of close to 100% within six months to a year. So you really have this disease that spans this entire spectrum. Thankfully, the percentage of patients who have anaplastic cancer is very, very low.

And then you have something called anaplastic or undifferentiated thyroid cancers, which probably is the most aggressive thyroid cancer in the human body with basically a mortality of close to 100% within six months to a year. So you really have this disease that spans this entire spectrum. Thankfully, the percentage of patients who have anaplastic cancer is very, very low.

And then you have something called anaplastic or undifferentiated thyroid cancers, which probably is the most aggressive thyroid cancer in the human body with basically a mortality of close to 100% within six months to a year. So you really have this disease that spans this entire spectrum. Thankfully, the percentage of patients who have anaplastic cancer is very, very low.

And most patients have papillary cancer, which is very, very treatable.